Unloading in Heart Failure Cardiogenic Shock

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 456 participants.

Also called NCT05064202

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 456 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05064202
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT05064202. Randomized; no masking; primary purpose treatment. Start 2023-10-01 (anticipated); primary completion 2027-10-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Unloading in Heart Failure Cardiogenic Shock
Acronym
UNLOAD HF-CS
Condition
Cardiogenic Shock
Intervention (Device)
Impella 5.5
Intervention (Drug)
Inotropes
Lead sponsor
Amsterdam UMC, location VUmc (class: other)
Collaborator
Abiomed Inc. (class: industry)

Record details

Record id
cardio:ct-nct05064202
Content hash
49d41bebf096723d26292c4742626d9c31a678835022ba2dded99f6ffb9bddc3